Skip to main content
. 2016 Jan 11;48(3):1016–1028. doi: 10.3892/ijo.2016.3327

Figure 1.

Figure 1

A schematic illustration of the TMT-based quantitative whole proteomic/phosphoproteomic pipeline. Cells treated with genistein for different time were subjected to FASP-based sample preparation. 6-plex TMT labeling and bRPLC fractionation were carried out and the collected fractions were concatenated. A portion of these fractions were subjected to TiO2 enrichment. Enriched phosphopeptides along with unprocessed peptides were analyzed at an Orbitrap-equipped mass spectrometer.